Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce the successful conclusion of negotiations with the pan ...

As treatment for spinal muscular atrophy (SMA) has drastically improved over the last decade, so too have survival rates and the number of people with SMA living well into adulthood. | A new education ...

In trading on Thursday, shares of Novartis (Symbol: NVS) crossed below their 200 day moving average of $85.90, changing hands as low as $85.60 per share. Novartis shares are currently trading off ...

Novartis on Tuesday said it had received approval in Switzerland for Coartem, which it said was the first drug to treat ...

Novartis said on Thursday that its Cosentyx drug had failed in a late-stage trial on adults with giant cell arteritis (GCA), ...

Novartis (Symbol: NVS) has been named to the Dividend Channel ''International S.A.F.E. 10'' list, signifying an international stock with above-average ''DividendRank'' statistics including a ...

The Novartis logo is seen on a new cell and gene therapy factory in Stein, Switzerland. (File photo by Arnd Wiegmann/Reuters) Swiss pharmaceutical giant Novartis announced it will spend $23 ...

Novartis on Monday confirmed its plans for a 100% spin-off of the Sandoz business on Oct. 4 after ... The Sandoz shares will have the symbol SDZ, Novartis said. Reporting by John Revill ...